8/3/2019 Abbot Annual Report1
1/2
Unaudited Financial results for the quarter and twelve months
ended November 30, 2010
(Rupees in Lakhs)
Sr.No Particulars 3 months ended 12 months ended
Nov 30,2010
Nov 30,2009
Nov 30,2010
Nov 30,2009
(Unaudited) (Unaudited) (Unaudited) (Audited)1 Net Sales/Income
from Operations
a Gross Sales 270,38 203,60 946,71 766,64
Less : Excise Duty 1,85 1,37 6,05 5,72
Net Sales 268,53 202,23 940,66 760,92
b Other Operating Income 8,93 10,70 26,19 23,41
2 Expenditure
a (Increase)/decrease in stock in trade
&work-in-progress
34,97 (2,06) 31,22 (10,78)
b Consumption of raw materials 11,03 11,30 40,85 46,12
c Purchase of Traded Goods 121,60 122,23 533,48 468,82d
Employees Cost 28,74 17,07 100,22 62,37
e Depreciation 3,16 2,70 9,96 9,01
f Other Expenditure 41,68 27,95 143,47 97,08
g Total Expenditure 241,18 179,19 859,20 672,62
3 Profit from Operations before Other Incomeand Interest
(1-2)
36,28 33,74 107,65 111,71
4 Other Income 2,05 99 6,02 5,87
5 Profit before Interest (3+4) 38,33 34,73 113,67 117,58
6 Interest - 7 1 20
7 Profit before Tax 38,33 34,66 113,66 117,38
8 Tax Expenses (including current tax,deferred taxation, fringe
benefit tax andprior period adjustments for the period)
12,80 11,01 38,36 39,87
9 Net Profit for the period 25,53 23,65 75,30 77,51
10 Paid- up Equity Share Capital(Face value of the share Rs.
10).
13,68 13,68 13,68 13,68
11 Reserves excluding revaluation reserves (asper last audited
balance sheet)
257,88
12 Basic and diluted Earnings per share for theperiods, for the
year to date (notannualized) and for the previous year Rs.
18.67 17.29 55.06 56.68
13 Public shareholdingNumber of SharesPercentage of
Shareholding
42,47,05631.06%
42,47,05631.06%
42,47,05631.06%
42,47,05631.06%
14 Promoters and promoter group shareholding
a Pledged/ EncumberedNumber of SharesPercentage of Shares
(as a % of the total shareholding ofpromoter and promoter
group)Percentage of Shares(as a % of the total share capital of
thecompany)
--
-
--
-
--
-
--
-
b Non - encumbered
Number of SharesPercentage of Shares(as a % of the total
shareholding ofpromoter and promoter group)
Percentage of Shares(as a % of the total share capital of
thecompany)
94,28,184100.00%
68.94%
94,28,184100.00%
68.94%
94,28,184100.00%
68.94%
94,28,184100.00%
68.94%
Notes :1. The results for the quarter and 12 months ended Nov
30, 2010 have been reviewed by the Audit Committee, approved by the
Board of Directors and
subjected to a Limited Review by the auditors of the Company, in
compliance with Clause 41 of the Listing Agreement with Bombay
StockExchange Limited.
8/3/2019 Abbot Annual Report1
2/2
2. Unaudited statement of assets and liabilities as at Nov 30,
2010
Particulars As at As at
Nov 30, 2010 Nov 30, 2009(Unaudited) (Audited)
Rs in Lakhs Rs in Lakhs
Shareholders Funds(a) Capital 13,68 13,68(b) Reserves and
Surplus 333,18 257,88
346,86 271,56
Deferred Tax Liability (Net) 24 2,20
Total 347,10 273,76
Fixed Assets 50,16 49,15
Current Assets, Loans and Advances(a) Inventories 70,67
102,38(b) Sundry Debtors 79,39 44,40(c) Cash and Bank Balances
212,55 175,61(d) Other Current Assets 97 43(e) Loans and Advances
25,64 10,95
389,22 333,77Less : Current Liabilities and Provisions(a)
Liabilities 66,09 57,90(b) Provisions 26,19 51,26
92,28 109,16
Net Current Assets 296,94 224,61
Total 347,10 273,76
3. The company continues to make strategic investments for
expanding its field force to improve market coverage and enhanced
promotional efforts toincrease market share.4. The Board of
Directors of the Company has, at its meeting held on November 24,
2010, unanimously approved the draft Scheme of Amalgamation
(Scheme) of Solvay Pharma India Limited into Abbott India
Limited under Sections 391 to 394 of the Companies Act, 1956,
subject to necessarystatutory approvals. The swap ratio for the
merger is 2:3 i.e. every two shares of Solvay Pharma India Limited
will entitle their holder to three sharesof Abbott India
Limited.
5. The Company has changed its financial year from December 1 -
November 30 to January 1 - December 31 from current year onwards.
Accordingly,the current financial year is for 13 months from 1
December 2009 to 31 December 2010. In terms of Clause 41 of the
Listing Agreement, the resultsfor quarter ended November 30, 2010
are being published. Also, the Company will be publishing the
results for the period from December 1, 2009 toDecember 31,
2010.
6. The Company operates in one reportable business segment i.e.
Pharmaceuticals and one reportable geographical segment i.e. Within
India.7. There were no Investor Complaints pending at the beginning
of the quarter. The Company received 5 complaints from the
investors and all the
complaints were resolved and disposed off during the quarter.
There were no complaints lying unresolved at the end of the
quarter.8. Figures for the prior year / period have been regrouped
and/or reclassified wherever considered necessary.
Abbott India Limited
Vivek MohanMumbai : Dec 21, 2010 Managing Director
